BRIEF-Navidea reports Q1 loss per share of $0.02
May 17, 2016 at 07:19 AM EDT
* Expects to begin grant-funded phase 1/2 evaluation of lymphoseek - iv in kaposi's sarcoma patients in second half of 2016
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.